国家药品价格谈判的法律规范框架研究

发布时间：2018-06-12 20:14

  本文选题：药品价格 + 价格谈判　； 参考：《中国卫生政策研究》2017年06期

【摘要】：药品的可及性是实现全民医保的基础条件,价格则是可及性的重要因素。专利药品和独家生产药品国家价格谈判工作必不可少,作为常态性工作,应将其纳入法治轨道,并制定相应原则和规则。在明确谈判的法律规范框架、构建立法原则的前提下,本文探讨了谈判主体及谈判对象的选择、谈判程序、谈判结果及其履行等具体内容,分析了现实存在的问题,并提出将来立法的相应规则。
[Abstract]:The availability of drugs is the basic condition for the realization of universal health insurance, and the price is the important factor of accessibility. It is necessary to negotiate the national price of patent drugs and exclusive manufactured drugs. As a normal work, they should be brought into the track of rule by law, and the corresponding principles and rules should be formulated. On the premise of defining the legal normative framework of negotiation and constructing legislative principles, this paper discusses the selection of subject and object of negotiation, negotiation procedure, negotiation result and its performance, and analyzes the problems existing in reality. And put forward the corresponding rules of future legislation.
【作者单位】： 北京大学公共卫生学院;
【分类号】：D922.2;R95
，

本文编号：2010924